BiotechTV - News

Barclays Miami: Arvinas will have an update next week for its LRRK2 targeting PROTAC for Parkinson's. The new CEO previews that and talks other targets they are working on

Mar 10, 2026
Ask episode
Chapters
Transcript
Episode notes